-
2
-
-
0031865023
-
Mechanism of action of leflunomide in rheumatoid arthritis
-
Fox RI (1998) Mechanism of action of leflunomide in rheumatoid arthritis. J Rheumatol 25 [Suppl 53]:20-26
-
(1998)
J Rheumatol
, vol.25
, Issue.53 SUPPL.
, pp. 20-26
-
-
Fox, R.I.1
-
3
-
-
0028792355
-
Safety and effectiveness of leflunomide in treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study
-
Mladenovic V, Domljan Z, Rozman B, Dodevic J, Popovic M, Dimitrijevic M, Zivkovic M, Campion G, (1995) Safety and effectiveness of leflunomide in treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study. Arthritis Rheum 38:1595-1603
-
(1995)
Arthritis Rheum
, vol.38
, pp. 1595-1603
-
-
Mladenovic, V.1
Domljan, Z.2
Rozman, B.3
Dodevic, J.4
Popovic, M.5
Dimitrijevic, M.6
Zivkovic, M.7
Campion, G.8
-
4
-
-
12644249109
-
In vitro and in vivo effects of leflunomide, brequiner, or cyclosporin on pyrimidine biosynthesis
-
Silva HT, Cao W, Shorthouse RA, Loffer M, Morris RE (1997) In vitro and in vivo effects of leflunomide, brequiner, or cyclosporin on pyrimidine biosynthesis. Transplant Proc 29:1292-1293
-
(1997)
Transplant Proc
, vol.29
, pp. 1292-1293
-
-
Silva, H.T.1
Cao, W.2
Shorthouse, R.A.3
Loffer, M.4
Morris, R.E.5
-
5
-
-
0030032806
-
The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase
-
Davis JP, Cain GA, Pitts WJ, Magolda RL, Copeland RA (1996) The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry 35:1270-1273
-
(1996)
Biochemistry
, vol.35
, pp. 1270-1273
-
-
Davis, J.P.1
Cain, G.A.2
Pitts, W.J.3
Magolda, R.L.4
Copeland, R.A.5
-
6
-
-
0345503095
-
Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans
-
Fairbanks LD, Bofil M, Ruckerman K, Simmonds HA (1995) Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. J Biol Chem 49:253-279
-
(1995)
J Biol Chem
, vol.49
, pp. 253-279
-
-
Fairbanks, L.D.1
Bofil, M.2
Ruckerman, K.3
Simmonds, H.A.4
-
7
-
-
0018823799
-
Pyrimidine nucleotide biosynthesis in animals genes, enzymes, and regulation of UMP biosynthesis
-
Jones ME (1980) Pyrimidine nucleotide biosynthesis in animals genes, enzymes, and regulation of UMP biosynthesis. Ann Rev Biochem 49:253-279
-
(1980)
Ann Rev Biochem
, vol.49
, pp. 253-279
-
-
Jones, M.E.1
-
8
-
-
0032804664
-
Mechanism of action for leflunomide in rheumatoid arthritis
-
Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Strand V, Kirschbaum BJ (1999) Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol 93:198-208
-
(1999)
Clin Immunol
, vol.93
, pp. 198-208
-
-
Fox, R.I.1
Herrmann, M.L.2
Frangou, C.G.3
Wahl, G.M.4
Morris, R.E.5
Strand, V.6
Kirschbaum, B.J.7
-
9
-
-
0032555586
-
Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans
-
Ruckemann K, Fairbanks LD, Carrey EA, Hawrylowicz CM, Richards DF, Kirschbaum B, Simmonds HA (1998) Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 273:21682-21691
-
(1998)
J Biol Chem
, vol.273
, pp. 21682-21691
-
-
Ruckemann, K.1
Fairbanks, L.D.2
Carrey, E.A.3
Hawrylowicz, C.M.4
Richards, D.F.5
Kirschbaum, B.6
Simmonds, H.A.7
-
10
-
-
0037378668
-
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis
-
Cutolo M, Sulli A, Ghiorzo P, Pizzorni C, Craviotto C, Villaggio B (2003) Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Ann Rheum Dis 62:297-302
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 297-302
-
-
Cutolo, M.1
Sulli, A.2
Ghiorzo, P.3
Pizzorni, C.4
Craviotto, C.5
Villaggio, B.6
-
11
-
-
0029585361
-
Importance of ribonucleotide availability to proliferating T lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibition
-
Fairbanks LD, Bofill M, Ruckemann K, Simmonds HA (1995) Importance of ribonucleotide availability to proliferating T lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibition. J Biol Chem 270:29682-29689
-
(1995)
J Biol Chem
, vol.270
, pp. 29682-29689
-
-
Fairbanks, L.D.1
Bofill, M.2
Ruckemann, K.3
Simmonds, H.A.4
-
12
-
-
0032773737
-
A771726, the active metabolite of leflunomide, directly inhibits activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner
-
Halminton LC, Vojnovic I, Warner TD (1999) A771726, the active metabolite of leflunomide, directly inhibits activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner. Br J Pharmacol 127:1589-1596
-
(1999)
Br J Pharmacol
, vol.127
, pp. 1589-1596
-
-
Halminton, L.C.1
Vojnovic, I.2
Warner, T.D.3
-
13
-
-
0028177579
-
Effects of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation
-
Weithmann KU, Jeske S, Schlotte V (1994) Effects of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation. Agents Actions 4:164-170
-
(1994)
Agents Actions
, vol.4
, pp. 164-170
-
-
Weithmann, K.U.1
Jeske, S.2
Schlotte, V.3
-
14
-
-
0001149081
-
Interactions between T cell plasma membrane and monocytes
-
Miossec P, Van der berg WB, Frestein GS (eds) Birkhäuser, Basel
-
Burger D, Dayer JM (1998) Interactions between T cell plasma membrane and monocytes. In: Miossec P, Van der berg WB, Frestein GS (eds) T cell arthritis. Birkhäuser, Basel, pp 111-128
-
(1998)
T Cell Arthritis
, pp. 111-128
-
-
Burger, D.1
Dayer, J.M.2
-
15
-
-
0030064262
-
Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro
-
Chong AS, Rezai K, Gebel HM, Finnegan A, Foster P, Xu X, Williams JW (1996) Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro. Transplantation 61:140-145
-
(1996)
Transplantation
, vol.61
, pp. 140-145
-
-
Chong, A.S.1
Rezai, K.2
Gebel, H.M.3
Finnegan, A.4
Foster, P.5
Xu, X.6
Williams, J.W.7
-
16
-
-
0029847123
-
A novel mechanism of action of the immunomodulatory drug, leflunomide: Augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2
-
Cao WW, Kao PN, Aoki Y, Xu JC, Shorthouse RA, Morris RE (1996) A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Transplant Proc 28:3079-3080
-
(1996)
Transplant Proc
, vol.28
, pp. 3079-3080
-
-
Cao, W.W.1
Kao, P.N.2
Aoki, Y.3
Xu, J.C.4
Shorthouse, R.A.5
Morris, R.E.6
-
17
-
-
0033596065
-
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate
-
Leflunomide Rheumatoid Arthritis Investigators Group
-
Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 159:2542-2550
-
(1999)
Arch Intern Med
, vol.159
, pp. 2542-2550
-
-
Strand, V.1
Cohen, S.2
Schiff, M.3
Weaver, A.4
Fleischmann, R.5
Cannon, G.6
Fox, R.7
Moreland, L.8
Olsen, N.9
Furst, D.10
Caldwell, J.11
Kaine, J.12
Sharp, J.13
Hurley, F.14
Loew-Friedrich, I.15
-
18
-
-
0029044362
-
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis
-
Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Galdsmith C, Katz LM, Lightfoot R, Paulus H, Strand V (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727-732
-
(1995)
Arthritis Rheum
, vol.38
, pp. 727-732
-
-
Felson, D.T.1
Anderson, J.J.2
Boers, M.3
Bombardier, C.4
Furst, D.5
Galdsmith, C.6
Katz, L.M.7
Lightfoot, R.8
Paulus, H.9
Strand, V.10
-
19
-
-
0033053835
-
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial
-
European Leflunomide Study Group
-
Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 353:259-263
-
(1999)
Lancet
, vol.353
, pp. 259-263
-
-
Smolen, J.S.1
Kalden, J.R.2
Scott, D.L.3
Rozman, B.4
Kvien, T.K.5
Larsen, A.6
Loew-Friedrich, I.7
Oed, C.8
Rosenburg, R.9
-
20
-
-
0034827629
-
Treatment of active rheumatoid arthritis with leflunomide: Two year follow up of a double blind, placebo controlled trial versus sulfasalazine
-
Scott DL, Smolen JS, Kalden JR, Van de Putte LB, Larsen A, Kvien IK, Oed C, Loew-Friedrich I, European Leflunomide Study Group (2001) Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis 60:913-923
-
(2001)
Ann Rheum Dis
, vol.60
, pp. 913-923
-
-
Scott, D.L.1
Smolen, J.S.2
Kalden, J.R.3
Van De Putte, L.B.4
Larsen, A.5
Kvien, I.K.6
Oed, C.7
Loew-Friedrich, I.8
Group, E.L.S.9
-
21
-
-
6744262231
-
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
-
Oxford
-
Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP(2000) A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 39:655-665
-
(2000)
Rheumatology
, vol.39
, pp. 655-665
-
-
Emery, P.1
Breedveld, F.C.2
Lemmel, E.M.3
Kaltwasser, J.P.4
-
22
-
-
0033509841
-
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis
-
Weinblatt M, Kremer JM, Coblyn JS (1999) Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 42:1322-1328
-
(1999)
Arthritis Rheum
, vol.42
, pp. 1322-1328
-
-
Weinblatt, M.1
Kremer, J.M.2
Coblyn, J.S.3
-
23
-
-
0036049636
-
Peripheral neuropathy: An unwanted effect of leflunomide?
-
Carully MT, Davies UM (2002) Peripheral neuropathy: an unwanted effect of leflunomide? Rheumatology 41:952-953
-
(2002)
Rheumatology
, vol.41
, pp. 952-953
-
-
Carully, M.T.1
Davies, U.M.2
-
24
-
-
0037350340
-
Leflunomide induced vasculitis - A dose-response relationship
-
Chan ATY, Bradlow A, McNally J (2003) Leflunomide induced vasculitis - a dose-response relationship. Rheumatology 42:492-493
-
(2003)
Rheumatology
, vol.42
, pp. 492-493
-
-
Chan, A.T.Y.1
Bradlow, A.2
McNally, J.3
-
26
-
-
1542636277
-
Anaerobic infections of the lung
-
Chung G, Goetz MB (2000) Anaerobic infections of the lung. Curr Infect Dis Rep 2:238-244
-
(2000)
Curr Infect Dis Rep
, vol.2
, pp. 238-244
-
-
Chung, G.1
Goetz, M.B.2
|